Adjuvant treatment with the bacterial lysate (OM-85) improves management of atopic dermatitis: A randomized study

• Christine Bodemer,

  Affiliation Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Department of Dermatology, Paris, France

  ⨯
• Gerard Guillet,

  Affiliation Université de Poitiers, Department of Dermatology, Poitiers, France

  ⨯
• Frederic Cambazard,

  Affiliation Université de St-Etienne, Hôpital de St-Etienne, Department of Dermatology, Saint-Etienne, France

  ⨯
• Franck Boralevi,

  Affiliation Université de Bordeaux, Hôpital Pellegrin-enfants, Pediatric Dermatology Unit, Bordeaux, France

  ⨯
• Stefania Ballarini,

  Affiliation Vifor Pharma/OM Pharma, Meyrin, Switzerland

  ⨯
• Christian Milliet,

  Affiliation Vifor Pharma/OM Pharma, Meyrin, Switzerland

  ⨯
• Paola Bertuccio,

  Affiliation Università degli Studi di Milano, Department of Clinical Sciences and Community Health, Milan, Italy

  ⨯
• Carlo La Vecchia,

  Affiliation Università degli Studi di Milano, Department of Clinical Sciences and Community Health, Milan, Italy

  ⨯
• Jean-François Bach ,

  * E-mail: jean-francois.bach@academie-sciences.fr

  Affiliations Université Paris Descartes, Sorbone Paris Cité, Paris, France, INSERM U1151- CNRS UMR 8253, INEM (Institut Necker Enfants Malades), Paris, France

  ⨯
• Yves de Prost

  Affiliation Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Department of Dermatology, Paris, France

  ⨯